Ginsenoside Rg3 Attenuates Angiotensin II-Mediated Renal Injury in Rats and Mice by Upregulating Angiotensin-Converting Enzyme 2 in the Renal Tissue.

In conclusion, Rg3 attenuates Ang II-mediated renal injury in rats and mice by upregulating ACE2 in the renal tissue. This research is the first to demonstrate that Rg3 increases tissue ACE2 levels in vivo. PMID: 31885658 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31885658?dopt=Abstract

Source: Evidence-based Complementary and Alternative Medicine - January 1, 2020 Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research

More News: Alternative and Complementary Therapies | Chronic Kidney Disease | Complementary Medicine | Urology & Nephrology